Research and Development Agreements - Schedule of Deferred Revenue, Other Liabilities for Co-share Payments and Accounts Receivable Balances from the Research and Development Agreements (Parenthetical) (Detail) $ in Millions |
Mar. 31, 2021
USD ($)
|
|---|---|
| Takeda Pharmaceuticals Inc | |
| Revenue Recognition [Line Items] | |
| Accounts payable to related party | $ 0.2 |
| X | ||||||||||
- Definition Revenue recognition. No definition available.
|
| X | ||||||||||
- Definition Carrying amount as of the balance sheet date of obligations due all related parties. For classified balance sheets, represents the current portion of such liabilities (due within one year or within the normal operating cycle if longer). Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Details
|